ACCESSIBILITY

24/7

Headlines

15:01

Justt raises $30M Series C amid chargeback market boom

15:00

Decart raises $32M in second funding round in two months, aims to rival OpenAI and Anthropic

12:57

CTech’s Book Review: Taking a generalist approach to today’s changing world

12:51

“We anticipate an improvement in the number of IPOs in 2025, as well as an increase in M&As”

Buzz

Most popular

Daily

Weekly

Four months after Intel shut it down, Ignite relaunches as an independent accelerator

Boomi acquires Israeli data management startup Rivery in $100M deal

Israel launches its first domestically built quantum computer

Chainalysis acquires Israeli blockchain security startup Hexagate in $60M deal

“I foresee one of the best decades in the history of the State of Israel”

More news

Biotech

20 stories about Biotech

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer

The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer

Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars

חברת תרופות סלג'ן סלג'ין Celgene משרדים סן דייגו קליפורניה

Celgene Backs Immunotherapy Company Biond Biologics

08.01.19|Meir Orbach

Biond develops immunotherapies for cancer and autoimmune diseases

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer

The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer

Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer

Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer

The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman

Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs

Former Teva Executives Raise $60 Million for Metabolic Disorders Venture

28.10.18|Lilach Baumer

The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer

The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer

The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer

Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer

The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich

The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution

MeMed בדיקת דם מימין ערן אדן ו כפיר עובד

Automated Blood Tests Startup MeMed Raises $70 Million to Expand Offering

20.09.18|Omer Kabir

The company will use the funding to launch a new model of its blood testing device, and to expand the range of tests it offers

Antiseptic Materials Startup Nobio Raises $3.6 Million

30.07.18|Asaf Shalev

The Israel-based startup plans to target the dental and medical device industry, offering technology to solve the infection and contamination when devices are placed in the body.

Cancer Screening Company Nucleix Raises 2.5 Million Euros

30.07.18|Lilach Baumer

Founded in 2008, Nucleix develops urine and blood-based non-invasive, molecular cancer screening tests

Eli Lilly Signs Multi-Year Collaboration with Anima Biotech

23.07.18|Lilach Baumer

Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones

Evogene Signs Brazilian Partnership to Develop Pest-Resistant Cotton

18.07.18|Lilach Baumer

Israel-based Evogene will identify pest-resistant genes in cotton, and Brazilian crop research Instituto Mato-Grossense do Algodão will test their effectiveness

Previous Articles More Articles